Hambardzumyan L - Search Results

1

Disparities in the consensus for treatment of chemotherapy-induced thrombocytopenia.

Hambardzumyan L, Grigoryan H, Badikyan M, Khachatryan H, Sargsyan N, Sulikhanyan A, Tamamyan G, Stebbing J. Hambardzumyan L, et al. Ecancermedicalscience. 2023 Nov 13;17:1627. doi: 10.3332/ecancer.2023.1627. eCollection 2023. Ecancermedicalscience. 2023. PMID: 38414967 Free PMC article.

2

Synthesis, Photophysical Properties and Antioxidant Activity of Novel Quinoline Derivatives.

Martiryan AI, Shahinyan GA, Aleksanyan IL, Hambardzumyan LP. Martiryan AI, et al. Among authors: hambardzumyan lp. J Fluoresc. 2023 Nov 28. doi: 10.1007/s10895-023-03519-2. Online ahead of print. J Fluoresc. 2023. PMID: 38015297

3

EFFECTS OF DIMETHYL SULFOXIDE ON HIPPOCAMPAL ACTIVITY IN A ROTENONE-INDUCED RAT MODEL OF PARKINSON'S DISEASE.

Darbinyan L, Simonyan K, Manukyan L, Hambardzumyan L. Darbinyan L, et al. Among authors: hambardzumyan l. Georgian Med News. 2023 Jun;(339):52-56. Georgian Med News. 2023. PMID: 37522774

4

Membrane-stabilizing and protective effects of curcumin in a rotenone-induced rat model of Parkinson disease.

Darbinyan LV, Simonyan KV, Hambardzumyan LE, Simonyan MA, Simonyan RM, Manukyan LP. Darbinyan LV, et al. Among authors: hambardzumyan le. Metab Brain Dis. 2023 Oct;38(7):2457-2464. doi: 10.1007/s11011-023-01237-z. Epub 2023 May 29. Metab Brain Dis. 2023. PMID: 37247135

5

Spectroscopic analysis of 2-(5-mercapto-1,3,4-oxadiazol-2-yl)-6-methylquinolin-4-ol binding to blood plasma albumin.

Grigoryan KR, Shilajyan HA, Zatikyan A, Aleksanyan I, Hambardzumyan L. Grigoryan KR, et al. Among authors: hambardzumyan l. Monatsh Chem. 2022;153(5-6):507-515. doi: 10.1007/s00706-022-02919-7. Epub 2022 May 9. Monatsh Chem. 2022. PMID: 35573272 Free PMC article.

6

Protective effect of curcumin against rotenone-induced substantia nigra pars compacta neuronal dysfunction.

Darbinyan LV, Simonyan KV, Hambardzumyan LE, Manukyan LP, Badalyan SH, Sarkisian VH. Darbinyan LV, et al. Among authors: hambardzumyan le. Metab Brain Dis. 2022 Apr;37(4):1111-1118. doi: 10.1007/s11011-022-00941-6. Epub 2022 Mar 3. Metab Brain Dis. 2022. PMID: 35239141

7

Protective effects of curcumin against rotenone-induced rat model of Parkinson's disease: in vivo electrophysiological and behavioral study.

Darbinyan LV, Hambardzumyan LE, Simonyan KV, Chavushyan VA, Manukyan LP, Badalyan SA, Khalaji N, Sarkisian VH. Darbinyan LV, et al. Among authors: hambardzumyan le. Metab Brain Dis. 2017 Dec;32(6):1791-1803. doi: 10.1007/s11011-017-0060-y. Epub 2017 Jul 10. Metab Brain Dis. 2017. PMID: 28695411

8

Rotenone impairs hippocampal neuronal activity in a rat model of Parkinson's disease.

Darbinyan LV, Hambardzumyan LE, Simonyan KV, Chavushyan VA, Manukyan LP, Sarkisian VH. Darbinyan LV, et al. Among authors: hambardzumyan le. Pathophysiology. 2017 Mar;24(1):23-30. doi: 10.1016/j.pathophys.2017.01.001. Epub 2017 Jan 22. Pathophysiology. 2017. PMID: 28126254 Free article.

9

Protective effects of hypothalamic proline-rich peptide and cobra venom Naja Naja Oxiana on dynamics of vestibular compensation following unilateral labyrinthectomy.

Galoyan AA, Khalaji N, Hambardzumyan LE, Manukyan LP, Meliksetyan IB, Chavushyan VA, Sarkisian VH, Sarkissian JS. Galoyan AA, et al. Among authors: hambardzumyan le. Neurochem Res. 2010 Nov;35(11):1747-60. doi: 10.1007/s11064-010-0239-7. Epub 2010 Aug 12. Neurochem Res. 2010. PMID: 20703940

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page